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Antiphospholipid syndrome (APS) is one of several prothrombotic states in
which thrombi occur within both the venous and arterial beds. A minority of
patients with APS present with an acute and devastating syndrome character-
ized by multiple simultaneous vascular occlusions throughout the body. “Cat-
astrophic APS” is defined by the clinical involvement of at least three different
organ systems over a period of days or weeks with histological evidence of
multiple occlusions of large or small vessels. We report the case of a 16-year-
old girl referred to our paediatric cardiology unit for NHYA IV and a blowing
systolic murmur at the apex radiating to the left axilla. Transthoracic echocar-
diography (TTE) revealed mitral valve leaflet thickening with vegetations
(13 mm) on the edges of both leaflets and moderate mitral regurgitation (MR)
(image 1). The diagnosis of Libman-Sacks or non-bacterial thrombotic
endocarditis secondary to antiphospholipid syndrome was suggested by
repeated negative blood cultures along with persistently elevated anticardio-
lipin antibody titers. The condition deteriorated to acute thrombotic microan-
giopathy affecting multiple organs with arterial hypertension and
thrombocytopenia. Anticoagulation with warfarin was peformed and aspirin,
corticosteroids and ACE inhibitors were given. TTE follow-up after 1.5 years
revealed no recurrence of MR with normal mitral valve leaflets. 
Conclusion: In catastrophic APS an aggressive therapeutic approach is war-
ranted. Valve lesions may become more severe during long term follow-up.
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Peak systolic Doppler velocity at the aortic isthmus alone is not a good pre-
dictor of severity in patients with native or residual coarctation (CoA). A
major argument in favour of a hemodynamically significant CoA is the pres-
ence of a diastolic gradient (DG) with characteristic “sawtooth” appearance of
the Doppler pattern. 
Aim of the study: to evaluate, in patients with some degree of aortic
isthmus narrowing but without significant DG at rest, if exercise could unmask
DG and thus hemodynamically significant CoA. 
Material and methods: Fourteen patients aged from 12 to 56 years under-
went treadmill exercise testing coupled with Doppler echocardiography. Thir-
teen had previous CoA repair 8 to 43 years before, one had aortic kinking with
mild isthmic narrowing on CT-scan. MRI or CT-scan were performed in
11 patients, showing significant residual stenosis (narrowing >30%) in 8/11.
Doppler measurements were performed during exercise testing and 5 minutes
after at the suprasternal notch, using a CW-Doppler 2 MHz pedoff probe. The
peak systolic and diastolic gradients through aortic isthmus were measured at
rest and at the end of the exercise. A peak DG > 17 mmHg was considered
significant.
Results: Mean peak systolic gradient increased from 29 to 65 mmHg with
exercise. Significant DG appeared in 4 of 8 patients without any DG at rest.
Among the 6 patients with non significant DG at rest, DG remained non sig-
nificant in 2 and became significant in 4. For the 11 patients with MRI or CT-
scan aortic arch evaluation, the specificity of significant DG at exercise was
100%, the sensitivity 75%, predictive positive value 100%, negative predictive
value 60%.
Conclusion: Apparition of a significant isthmic Doppler DG at exercise
can reliably predict the hemodynamic significance of restenosis after CoA
repair, as well as native narrowing of the aorta. This simple, safe and effective
non-invasive method may help to identify patients requiring surgery or percu-
taneous stenting.
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Introduction: Levosimendan (Lev) is a new calcium sensitizer and K-ATP
channel opener. The documentation regarding this drug is one of the largest
ever on the safety and efficacy of a new pharmacological agent in acute heart
failure syndromes in adult population. Its use in paediatric is limited to suc-
cessful weaning from biventricular mechanical support in case reports or small
trials conducted in the immediate postoperative period. We report our experi-
ence of using (Lev) during refractory cardiogenic shock (RCS) in infants. 
Patients and Methods: Four infants aged 2-24 months and suffering from
hypokinetic dilated cardiomyopathy) were included in this study. All presented
with uncontrolled RCS (LVEF <20%) despite conventional inotropes treat-
ment. Lev was intended as a last resort before ECMO. The effectiveness of
treatment was monitored by measuring the echocardiographic left ventricular
ejection fraction (LVEF) and plasma BNP assay before and 8 days after
administration. A total of 15 injections of Lev were realized and studied.
Results: Mean LVEF before and 8 days after administration of Lev signif-
icantly increase from 19.75 % +/- 1.7 to 33 +/- 2.95 (p<0.01) and mean BNP
level decrease from 2267 pg/ml +/- 518 to 1673 +/- 372 (p<0.08). These chil-
dren could benefit from additional treatments of Lev in order to wean amines
and defer the circulatory support. In one of these, a total of 6 cycles was nec-
essary without the use of circulatory support for an improvement. In the
4 patients studied, the outcome was favorable. Figure 1 illustrates the indi-
vidual changes in LVEF and BNP after each Lev injection.
Conclusion: During the refractory cardiogenic shock of the child with
hypokinetic dilated cardiomyopathy, levosimendan may improve myocardial
function allowing weaning of conventional inotropes and circulatory support.
Re-injection may also be necessary. Randomized studies with larger number
of patients are needed to confirm these very encouraging results. 
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Introduction and objectives: Percutaneous closure of patent ductus arteri-
osus (PDA) is a well-established technique. We evaluated the usefulness of the
Amplatzer duct occluder (ADO) for the percutaneous closure of large patent
ductus arteriosus in 16 children less than 2 years of age.
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Methods: The patient’s mean age was 15, 5 months (from 6 to 24 months)
and their mean weight was 8, 6 (4- 13, 5) kg. In addition, 2 patients were
under 5 Kg. mean symptoms were recurrent pulmonary infections (7 patients),
dyspnea (5 patients) and 2 of them had patent cardiac failure. All completed
follow-up (3 months – 6 years). 
Results: The mean PDA diameter was 4.4, 8(2- 6) mm. dilated left ventric-
ular was noticed in all cases and pulmonary hypertension within 7 cases. The
device was implanted successfully in all the patients. Sizes of the device were
10/8 in one case, 8/6 in 9 cases, 6/4 in 6 cases. Aortography showed initial
total occlusion in 65.8% of patients. At 3-month follow-up, total occlusion
was observed in 100% of patients. No deaths or significant complications were
associated with the procedure during the study period. One patient develop
hemopericardium with tamponade witch treated successfully by pericardiocen-
tesis.
Conclusions: In children under 2 years of age, percutaneous closure of
large patent ductus arteriosus using an Amplatzer occluder was a safe and
effective procedure.
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Purpose: Right ventricular outflow tract (RVOT) reconstruction in infancy
or childhood leads to lifetime iterative surgery for pulmonary stenosis or
regurgitation. Transcatheter pulmonary valve implantation (TPVI) was devel-
oped with the aim to reduce the number of reoperations and operative-related
morbidity. 
Methods and Results: From 12/2008 to 03/2010, 21 patients were referred
to Marie-Lannelongue Hospital for TPVI. Mean age was 24 yrs (11.5-55 yrs),
mean weight was 60 kg (20-85 kg). Most of them had a Tetralogy of Fallot
variant (n=12) and 70% had 3 or more previous surgery. RVOT stenosis  was
predominant in 90% of patients. RVOT reconstruction techniques were :
valved conduit (n=12), non-valved conduit (n=1), homograft (n=6), RVOT
patch (n=2). RVOT balloon inflation test was performed only if cardiac CT
scan showed coronary arteries located next to the RVOT. Two patients were
excluded, 1 because an aorto-pulmonary fistula after Ross operation, and 1
with previous arterial switch because of compression of the reimplanted left
coronary artery at RVOT balloon inflation test. Initial stenting and TPVI were
performed during the same procedure in 18/19. There was immediate signifi-
cant decrease in right ventricular systolic pressure (mean 88.6 to 52.2 mmHg),
mean RVOT gradient (mean 43.7 to 22 mmHg) and pulmonary regurgitation
(grade 2 or more before, none after). One patient with a 16mm homograft had
significant residual stenosis (mean RVOT gradient 45 mmHg) after Melody
implantation. All patients were discharged within 2 days. At a mean follow-up
of 9.3 months (1 to 24 months) all patients are alive and well and neither
Melody valve dysfunction nor stent fracture or migration was noticed.  
Conclusion: Percutaneous pulmonary valve implantation is a safe alterna-
tive to surgery. Our experience suggests that patients with RVOT conduit < 18
mm and those with previous arterial switch operation should be referred to
surgery without considering transcatheter procedure.
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Introduction: Percutaneous pulmonary valve insertion has been recently
introduced in clinical setting. Patient selection is widely accepted. Initial
results demonstrated early and differed stent fractures that make consider pre-
stenting as a previous step for the procedure. To date, differed or intra-proce-
dure pre-stenting are both accepted techniques.
Patients and methods: We reviewed patients included over the last
6 months in the prospective study (REVALV) for patients undergoing RVOT
intervention for severe stenosis and/or insufficiency. Only valved stent group
is analyzed here. All patients undergoing valved stent implantation are pre-
viously pre-stented with a bare metal stent according to present recommenda-
tions. Thirty-seven patients were included, distributed in two gropus according
moment of pre-stenting: differed pre-stenting (bare metal stent implantation
several days before valved stent implantation -20 patients-) and same proce-
dure pre-stenting (bare metal stent implantation at the same procedure of
valved stent implantation-17 patients-). For analytical purposes, we considered
RVOT anatomy (homograft, synthetic tube, patch-extended RVOT or native
outflow tract).
Results: Overall, no differences were found regarding mean procedure
times (77,35 vs 96,88, p=NS)and time of hospitalization (2,95 vs 3,63, p=NS).
Mean delay time from pre-stenting to valvulation was 196,5+-68 days. Rv to
Ao ratio improvement from basal to valvulation was significantly better in
intra-procedure pre-stenting group (0,172 vs 0,373, p=0,009). Concerning
complications,bare metal stent mobilization happened just after implantation
while trying to place valved stent delivery gain. Two pelvic hematomas were
observed (one of each group).
Conclusions: Intra-procedure pre-stenting influences final result when con-
sidering RV-to-Ao ratio improvement, probably related to increase radial
strength. The risk, however, remains higher as freshly implanted bare metal
stent can mobilize, especially in native RVOT. Stratification of patient should
be considered while choosing candidates for valved stent implantation.
317
Effect of aging at repair on Tissue Doppler imaging parameters in
patients with aortic coarctation 
Sana Ouali, Sami Hammas, Rim Gribaa, Slim Kacem, Elyes Neffeti,
Fahmi Remedi, Essia Boughzela
Hôpital Sahloul, Cardiologie, Sousse, Tunisie
Background: Despite successful repair of aortic coarctation (AoC),
changes in the left ventricular (LV) regional myocardial function are reported.
The aim of this study was to assess the left ventricular systolic function in
patients after the successful repair of aortic coarctation using tissue Doppler
imaging (TDI) according to the age of aortic coarctation repair.
Methods: 31 patients (mean age, 12.0 +/- 4.2 years) followed up after a suc-
cessful chirurgical repair of aortic coarctation (mean follow up, 8,6 ±7,6 years)
were studied by echocardiography . The study population was divided in two
groups: patients repaired at age  2 years (Group 1, n=17) and patients repaired
at age > 2 years (group 2, n=14). The TDI parameters and the conventional
echocardiographic indices of the left ventricular systolic function were analyzed
and compared between the two groups.
Results: Standard echocardiographic studies revealed normal global left
ventricular (LV) function. The LV dimensions, LV ejection fraction, LV short-
ening fraction, indexed LV mass did not differ between the examined groups.
Among the studied LV filling parameters, peak early (E wave) transmitral
flow velocity, as well as deceleration time DT, was similar between the two
groups. The Tei index was also not affected by the age at repair of aortic
coarctation. Regarding TDI measures, the early diastolic and the systolic
velocities on the lateral side of the mitral annulus were significantly higher in
group 1 than in group 2 (Sa : 12,7±2,59 cm/s vs 10,6± 1,8 cm/s, p=0,025 ; Ea :
20,7± 3,4 cm/s vs 17,3± 4,7 cm/s, p= 0,03) . TDI velocities on the septal side
of the mitral annulus and on the right ventricle (RV) free wall side of the tri-
cuspid annulus were not different between early ( before 2 years) and late
(after 2 years) repair of the aortic coarctation. There were no differences of the
TDI or conventional parameters between hypertensive and normotensive
patients.
Conclusion: Left ventricular systolic performance in patients after the sur-
gical repair of aortic coarctation reveals tendency to decrease at follow-up in
patients repaired at age > 2 years despite a satisfactory results after surgery. 
